Invesco

Invesco’s UroGen Pharma URGN Stock Holding History

Invesco’s Portfolio URGN Stock Details URGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$505K	Buy	28,080 +1,014	+4%	+$20.3K	﹤0.01%	3159
2025 Q4	$634K	Buy	27,066 +4,711	+21%	+$102K	﹤0.01%	3114
2025 Q3	$446K	Buy	22,355 +9,614	+75%	+$173K	﹤0.01%	3274
2025 Q2	$175K	Buy	12,741 +31	+0.2%	+$297	﹤0.01%	3549
2025 Q1	$141K	Sell	12,710 -746	-6%	-$7.95K	﹤0.01%	3585
2024 Q4	$143K	Buy	13,456 +634	+5%	+$7.59K	﹤0.01%	3575
2024 Q3	$163K	Buy	12,822 +1,159	+10%	+$17.2K	﹤0.01%	3552
2024 Q2	$196K	Buy	11,663 +905	+8%	+$12.9K	﹤0.01%	3627
2024 Q1	$161K	Buy	10,758 +656	+6%	+$10.7K	﹤0.01%	3687
2023 Q4	$152K	Buy	10,102 +47	+0.5%	+$610	﹤0.01%	3615
2023 Q3	$141K	Buy	+10,055	New	+$161K	﹤0.01%	3673
2019 Q1	–	Sell	-6,078	Closed	-$262K	–	3821
2018 Q4	$262K	Buy	+6,078	New	+$273K	﹤0.01%	3491

Other funds holding URGN

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Toronto Dominion Bank

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $51.9B AUM 40.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return

Jefferies Financial Group New York $8.2B AUM 40.95% 1-Year Est. Return

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

SG Americas Securities

SG Americas Securities New York $90.6B AUM 36.98% 1-Year Est. Return

American Century Companies

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return